- Home
- Standardized Extracts
- Voacanga Extract
Voacanga Extract (Voacanga africana) – Voacangine 1–5%
Voacanga africana
Pharmaceutical active / prescription-only in many markets
Orders are released after a compliance review of the intended use and destination market.
- Marker compound
- Voacangine
- Standardisation
- 1–5% (HPLC)
- Assay method
- HPLC
- Plant part
- Seed
- Origin
- Ghana, Cameroon
Voacanga Extract (Voacanga africana) – Voacangine 1–5%
Voacanga extract is produced from the seed of Voacanga africana (Apocynaceae family) and supplied as a standardized extract powder, standardized to Voacangine. Available grades: 1%, 5%. Typical sourcing: Ghana, Cameroon. For B2B formulation in pharmaceutical.
1%5%
Specifications
| Botanical name | Voacanga africana |
| Common names | Voacanga |
| Plant family / part | Apocynaceae / Seed |
| Marker compound | Voacangine |
| Phytochemical class | Alkaloids › Indole & β-carboline alkaloids |
| Available grades | 1%, 5% |
| Assay method | HPLC |
| Form | Standardized Extract |
| Origin | Ghana, Cameroon |
| Pack sizes | Sample (50 g), 250 g, 1 Kg, 5 Kg, 25 Kg |
| Shelf life & storage | Typically 24 months in sealed original packaging; store cool, dry and away from light |
Regulatory status
- Pharmaceutical active / prescription-only in many markets
Supplied only to qualified business buyers for lawful manufacturing, research or pharmaceutical use. Buyers are responsible for compliance in their market.
Industries
Pharmaceutical
Documentation
The Technical Data Sheet and Safety Data Sheet (GHS format) can be downloaded from this page; the batch Certificate of Analysis is supplied on request. Confirm the assay method (HPLC, UV or gravimetric) on the CoA, as results differ between methods.
For B2B formulation and research use. Statements have not been evaluated by the FDA or other regulators; this ingredient is not intended to diagnose, treat, cure or prevent any disease.
Browse related
Same product form